MARC details
| 000 -LEADER |
|---|
| fixed length control field |
14538cam a2200553 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
GVRL8GLJ |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
MiFhGG |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20210202122934.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr un ---uuuua |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
141211t20152015miua obe 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
9781410317445 |
| Qualifying information |
(electronic book) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781410317407 |
| Qualifying information |
(hardback : set) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781410317414 |
| Qualifying information |
(vol. 1) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781410317421 |
| Qualifying information |
(vol. 2) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781410317438 |
| Qualifying information |
(vol. 3) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)905548004 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
MiFhGG |
| Language of cataloging |
eng |
| Transcribing agency |
MiFhGG |
| Description conventions |
rda |
| -- |
pn |
| 050 #4 - Library of Congress Classification |
|---|
| Library of Congress Class mark |
RC254.5 |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QZ 13 |
| 245 04 - TITLE STATEMENT |
|---|
| Title |
The Gale encyclopedia of cancer : |
| Subtitle |
a guide to cancer and its treatments / |
| Statement of responsibility, etc |
Kristin Fust, editor. |
| 246 1# - VARIANT TITLE |
|---|
| Title |
Encyclopedia of cancer |
| 250 ## - EDITION |
|---|
| Edition statement |
Fourth edition. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Farmington Hills, Mich. : |
| Name of producer, publisher, distributor, manufacturer |
Gale, Cengage Learning, |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2015] |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
©2015 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Physical description |
1 online resource (3 volumes (2063 pages)) : |
| Other physical details |
illustrations (chiefly color) |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Source |
rdacarrier |
| 490 0# - SERIES TITLE |
|---|
| Series statement |
Gale virtual reference library |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - CONTENTS |
|---|
| Contents |
Abarelix -- Accelerated partial breast irradiation -- Acoustic neuroma -- Acute erythroblastic leukemia -- Acute lymphocytic leukemia -- Acute myelocytic leukemia -- Adenocarcinoma -- Adenoma -- Adjuvant chemotherapy -- Ado-trastuzumab emtansine -- Adrenal fatigue -- Adrenal tumors -- Adrenocortical carcinoma -- Adult cancer pain -- Advance directives -- Afatinib -- AIDS-related cancers -- Alcohol consumption and cancer -- Aldesleukin -- Alemtuzumab -- Allopurinol -- Alopecia -- Altretamine -- Amantadine -- Amenorrhea -- American joint committee on cancer -- Amifostine -- Aminoglutethimide -- Amitriptyline -- Amputation -- Amsacrine -- Anagrelide -- Anal cancer -- Anemia -- Angiogenesis -- Angiogenesis inhibitors -- Angiography -- Anorexia -- Anoscopy -- Antiandrogens -- Antibiotics -- Anticancer drugs -- Antidiarrheal agents -- Antiemetics -- Antiestrogens -- Antifungal therapy -- Antimicrobials -- Antineoplastic agents -- Antioxidants -- Antiviral therapy -- Aromatase inhibitors -- Arsenic trioxide -- Ascites -- Asparaginase -- Astrocytoma -- Axillary dissection -- Azacitidine -- Azathioprine -- Bacillus Calmette-Gu�rin -- Barium enema -- Barrett's esophagus -- Basal cell carcinoma -- BCR-ABL inhibitors -- Bendamustine hydrochloride -- Benzene -- Benzodiazepines -- Bevacizumab -- Bexarotene -- Bile duct cancer -- Biological response modifiers -- Biopsy -- Bisphosphonates -- Bladder cancer -- Bleomycin -- Body image/self image -- Bone marrow aspiration and biopsy -- Bone marrow transplantation -- Bone pain -- Bone survey -- Bortezomib -- Bowen disease -- Brain and central nervous system tumors -- Brca1 and brca2 -- Breast cancer -- Breast reconstruction -- Breast self-exam -- Breast ultrasound -- Bronchoalveolar lung cancer -- Bronchoscopy -- Burkitt lymphoma -- Buserelin -- Busulfan -- Calcitonin -- Cancer -- Cancer biology -- Cancer cluster -- Cancer diet -- Cancer genetics -- Cancer of unknown primary -- Cancer predisposition -- Cancer prevention -- Cancer research -- Cancer screening guidelines for men -- Cancer screening guidelines for women -- Cancer survivorship issues -- Cancer therapy, palliative -- Cancer vaccines -- Cancer-fighting foods -- Capecitabine -- Capsaicin -- Carbamazepine -- Carboplatin -- Carcinogenesis -- Carcinogens -- Carcinoid tumors, gastrointestinal -- Carcinoid tumors, lung -- Carcinoma -- Carcinomatous meningitis -- Cardiomyopathy -- Carmustine -- Cartilage supplements -- Castleman disease -- Central nervous system carcinoma -- Central nervous system lymphoma -- Cervical cancer -- Cetuximab -- Chemoembolization -- Chemoprevention -- Chemotherapy -- Childhood cancers -- Chlorambucil -- Chondrosarcoma -- Chordoma -- Choroid plexus tumors -- Chromosome rearrangements -- Chronic lymphocytic leukemia -- Chronic myelocytic leukemia -- Cigarettes -- Cisplatin -- Cladribine -- Clinical trials -- Coenzyme q10 -- Colectomy -- Colon cancer -- Colonoscopy -- Colorectal surgery -- Colostomy -- Complementary cancer therapies -- Computed tomography -- Cone biopsy -- Corticosteroids -- Craniopharyngioma -- Craniosynostosis -- Craniotomy -- Cryotherapy -- Ct-guided biopsy -- Cushing syndrome -- Cutaneous t-cell lymphoma -- Cyclooxygenase 2 inhibitors -- Cyclophosphamide -- Cyclosporine -- Cystectomy -- Cystosarcoma phyllodes -- Cystoscopy -- Cytarabine -- Cytogenetic analysis -- Cytology -- Dabrafenib -- Dacarbazine -- Daclizumab -- Dactinomycin -- Danazol -- Dasatinib -- Daunorubicin -- Debulking surgery -- Degarelix -- Demeclocycline -- Denileukin diftitox -- Denosumab -- Depression -- Dexamethasone -- Dexrazoxane -- Diarrhea -- Diazepam -- Dietary factors and cancer risk -- Diethylstilbestrol diphosphate -- Digital rectal examination -- Dilatation and curettage -- Diphenhydramine -- Disseminated intravascular coagulation -- DNA flow cytometry -- Docetaxel -- Doxorubicin -- Drug resistance -- Ductogram -- Dutasteride -- Endocrine system tumors -- Endometrial cancer -- Endorectal ultrasound -- Endoscopic retrograde cholangiopancreatography -- Enteritis -- Environmental factors in cancer development -- Ependymoma -- Epidermal growth factor receptor antagonists -- Epirubicin -- Epstein-Barr virus -- Erlotinib -- Erythropoiesis-stimulating agents -- Esophageal cancer -- Esophageal resection -- Esophagogastrectomy -- Essiac -- Estramustine -- Etoposide -- Everolimus -- Ewing sarcoma -- Exenteration -- Extracranial germ cell tumors -- Extragonadal germ cell tumors -- |
| 505 8# - CONTENTS |
|---|
| Contents |
Familial cancer syndromes -- Family and caregiver issues -- Fanconi anemia -- Fatigue -- Fecal occult blood test -- Fertility issues -- Fever -- Fibrocystic condition of the breast -- Fibrosarcoma -- Filgrastim -- Flow cytometry -- Floxuridine -- Fludarabine -- Fluorouracil -- Fluoxymesterone -- Folic acid -- Gabapentin -- Gallbladder cancer -- Gallium nitrate -- Gallium scan -- Gastrectomy -- Gastroduodenostomy -- Gastrointestinal cancers -- Gastrointestinal complications -- Gefitinib -- Gemcitabine -- Gemtuzumab -- Gene therapy -- Genetic testing -- Germ cell tumors -- Gestational trophoblastic tumors -- Giant cell tumors -- Global cancer incidence and mortality -- Glossectomy -- Glutamine -- Goserelin acetate -- Graft-versus-host disease -- Gynecologic cancers -- Hairy cell leukemia -- Hand-foot syndrome -- Head and neck cancers -- Health insurance -- Hemolytic anemia -- Hemoptysis -- Heparin -- Hepatic arterial infusion -- Herpes simplex -- Herpes zoster -- Histamine 2 antagonists -- Hodgkin lymphoma -- Home health services -- Horner syndrome -- Hospice care -- Human growth factors -- Human papillomavirus -- Hydroxyurea -- Hypercalcemia -- Hypercoagulation disorders -- Hyperthermia -- Hypocalcemia -- Ibritumomab -- Idarubicin -- Ifosfamide -- Imaging studies -- Imatinib mesylate -- Immune globulin -- Immune response -- Immunoelectrophoresis -- Immunohistochemistry -- Immunotherapy -- Incontinence, cancer-related -- Infection and sepsis -- Intensity-modulated radiation therapy -- Interferons -- Interleukin 2 -- Intrathecal chemotherapy -- Intravenous urography -- Investigational drugs -- Irinotecan -- Itching -- Kaposi sarcoma -- Ki67 -- Kidney cancer -- Lambert-eaton myasthenic syndrome -- Laparoscopy -- Lapatinib -- Laryngeal cancer -- Laryngeal nerve palsy -- Laryngectomy -- Laryngoscopy -- Late effects of cancer treatment -- Laxatives -- Leiomyosarcoma -- Leucovorin -- Leukemias, acute -- Leukemias, chronic -- Leukoencephalopathy -- Leukotriene inhibitors -- Leuprolide acetate -- Levamisole -- Li-Fraumeni syndrome -- Limb salvage -- Lip cancer -- Liver biopsy -- Liver cancer -- Lobectomy -- Lomustine -- Lorazepam -- Low molecular weight heparins -- Lumbar puncture -- Lumpectomy -- Lung biopsy -- Lung cancer, non-small cell -- Lung cancer, small cell -- Lymph node biopsy -- Lymph node dissection -- Lymphangiography -- Lymphocyte immune globulin -- Lymphoma -- Magnetic resonance imaging -- Male breast cancer -- Malignant fibrous histiocytoma -- Malt lymphoma -- Mammography -- Mantle cell lymphoma -- Mastectomy -- Matrix metalloproteinase inhibitors -- Mechlorethamine -- Meclizine -- Mediastinal tumors -- Mediastinoscopy -- Medroxyprogesterone acetate -- Medulloblastoma -- Megestrol acetate -- Melanoma -- Melphalan -- Memory change -- Meningioma -- Meperidine -- Mercaptopurine -- Merkel cell carcinoma -- Mesna -- Mesothelioma -- Metastasis -- Methotrexate -- Methylphenidate -- Metoclopramide -- Micronutrients and cancer prevention -- Mistletoe -- Mitomycin-C -- Mitotane -- Mitoxantrone -- Modified radical mastectomy -- Mohs surgery -- Monoclonal antibodies -- Mucositis -- Multiple endocrine neoplasia -- Multiple myeloma -- Myasthenia gravis -- Mycophenolate mofetil -- Mycosis fungoides -- Myelodysplastic syndromes -- Myelofibrosis -- Myeloma -- Myeloproliferative diseases -- Myelosuppression -- Nasal cancer -- Nasopharyngeal cancer -- National cancer institute -- National comprehensive cancer network -- Nausea and vomiting -- Nephrectomy -- Nephrostomy -- Neuroblastoma -- Neuroendocrine tumors -- Neuropathy -- Neurotoxicity -- Neutropenia -- Night sweats -- Nilotinib -- Non-Hodgkin lymphoma -- Nonsteroidal anti-inflammatory drugs -- Nuclear medicine scans -- Nutritional support -- Obesity and cancer risk -- Obinutuzumab -- Occupational exposures and cancer -- Ofatumumab -- Oligodendroglioma -- Omega-3 fatty acids -- Ommaya reservoir -- Oncologic emergencies -- Oophorectomy -- Opioids -- Oprelvekin -- Oral cancers -- Orchiectomy -- Oropharyngeal cancer -- Osteosarcoma -- Ovarian cancer -- Ovarian epithelial cancer -- |
| 505 0# - CONTENTS |
|---|
| Contents |
Paget disease of the breast -- Pain management -- Pancreatectomy -- Pancreatic cancer -- Pancreatic cancer, endocrine -- Pancreatic cancer, exocrine -- Panitumumab -- Pap test -- Paracentesis -- Paranasal sinus cancer -- Paraneoplastic syndromes -- Parathyroid cancer -- PC-spes -- Pegaspargase -- Pemetrexed -- Penile cancer -- Pentostatin -- Percutaneous transhepatic cholangiography -- Pericardial effusion -- Pericardiocentesis -- Peritoneovenous shunt -- Pesticides -- Peutz-jeghers syndrome -- Pharyngectomy -- Phenytoin -- Pheochromocytoma -- Pheresis -- Photodynamic therapy -- Physical therapy -- Pilocarpine -- Pineoblastoma -- Pituitary tumors -- Plerixafor -- Pleural biopsy -- Pleural effusion -- Pleurodesis -- Plicamycin -- Ploidy analysis -- Pneumonectomy -- Pneumonia -- Polyomavirus hominis type 1 (BK virus) infection -- Pomalidomide -- Porfimer sodium -- Positron emission tomography -- Pregnancy and cancer -- Primary site -- Procarbazine -- Prostate cancer -- Prostatectomy -- Protein electrophoresis -- Proteomics -- Psycho-oncology -- Quadrantectomy -- Radiation dermatitis -- Radiation therapy -- Radical neck dissection -- Radiofrequency ablation -- Radiofrequency energy and cancer risk -- Radiopharmaceuticals -- Raloxifene -- Ramucirumab -- Receptor analysis -- Reconstructive surgery -- Rectal cancer -- Rectal resection -- Regorafenib -- Renal pelvis tumors -- Retinoblastoma -- Rhabdomyosarcoma -- Richter syndrome -- Rituximab -- Salivary gland tumors -- Sarcoma -- Sargramostim -- Saw palmetto -- Scopolamine -- Screening test -- Second cancers -- Secondhand smoke -- Second-look surgery -- Segmentectomy -- Semustine -- Sentinel lymph node biopsy -- Sentinel lymph node mapping -- Sexual issues for cancer patients -- Sezary syndrome -- Sigmoidoscopy -- Simple mastectomy -- Sipuleucel-T -- Sirolimus -- Skin biopsy -- Skin cancer -- Skin cancer, non-melanoma -- Skin check -- Small intestine cancer -- Smoking cessation -- Soft tissue sarcoma -- Sorafenib -- Spinal axis tumors -- Spinal cord compression -- Spiritual and ethical concerns -- Splenectomy -- Squamous cell carcinoma of the skin -- Stem cell transplantation -- Stenting -- Stereotactic needle biopsy -- Stereotactic surgery -- Stomach cancer -- Stomatitis -- Streptozocin -- Substance abuse -- Sunitinib -- Superior vena cava syndrome -- Supratentorial primitive neuroectodermal tumors -- Suramin -- Surgical oncology -- Survivorship care plans -- Syndrome of inappropriate antidiuretic hormone -- Tacrolimus -- Tamoxifen -- Tanning -- Taste alteration -- Temozolomide -- Temsirolimus -- Teniposide -- Testicular cancer -- Testicular self-exam -- Testolactone -- Testosterone -- Tetrahydrocannabinol -- Thalidomide -- Thioguanine -- Thiotepa -- Thoracentesis -- Thoracic surgery -- Thoracoscopy -- Thoracotomy -- Thrombocytopenia -- Thrombopoietin -- Thrush -- Thymic cancer -- Thymoma -- Thyroid cancer -- Thyroid nuclear medicine scan -- Topotecan -- Toremifene -- Tositumomab -- Tracheostomy -- Trametinib -- Transfusion therapy -- Transitional care -- Transitional cell carcinoma -- Transurethral bladder resection -- Transvaginal ultrasound -- Transverse myelitis -- Trastuzumab -- Tretinoin -- Trichilemmal carcinoma -- Trimetrexate -- Triple negative breast cancer -- Triptorelin pamoate -- Tube enterostomy -- Tumor grading -- Tumor lysis syndrome -- Tumor markers -- Tumor necrosis factor -- Tumor removal -- Tumor staging -- Ultrasonography -- Upper gastrointestinal endoscopy -- Upper gastrointestinal series -- Ureterosigmoidostomy -- Ureterostomy, cutaneous -- Urethral cancer -- Urostomy -- Vaginal cancer -- Valrubicin -- Vascular access -- Vinblastine -- Vincristine -- Vindesine -- Vinorelbine -- Vitamins -- Von Hippel-Lindau disease -- Von recklinghausen neurofibromatosis -- Vorinostat -- Vulvar cancer -- Waldenstrom macroglobulinemia -- Warfarin -- Weight loss -- Whipple procedure -- Whole brain radiotherapy -- Wilms tumor -- Xerostomia -- X-rays -- Zoledronate -- Zollinger-Ellison syndrome -- Zolpidem. |
| 520 ## - Summary |
|---|
| Summary |
Comprehensive survey of cancers, cancer drugs, traditional and alternative treatments, side effects and diagnostic procedures. |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Oncology |
| Form subdivision |
Encyclopedias. |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Cancer |
| Form subdivision |
Encyclopedias. |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
Fust, Kristin, |
| Relator term |
editor. |
| 710 2# - ADDED CORPORATE NAME |
|---|
| Added corporate author |
Gale Group. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Relationship information |
Print version: |
| Title |
Gale encyclopedia of cancer. |
| Place, publisher, and date of publication |
Farmington Hills, Mich. : Gale, Cengage Learning, [2015] |
| International Standard Book Number |
9781410317407 |
| 856 40 - ONLINE RESOURCE |
|---|
| Uniform Resource Identifier |
<a href="http://link.galegroup.com/apps/pub/8GLJ/GVRL?sid=gale_marc&u=bilk_itc">http://link.galegroup.com/apps/pub/8GLJ/GVRL?sid=gale_marc&u=bilk_itc</a> |
| Public note |
Click here to access |
| 336 ## - CONTENT TYPE |
|---|
| Content type code |
txt |
| 337 ## - MEDIA TYPE |
|---|
| Media type code |
c |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type code |
cr |
| 588 ## - SOURCE OF DESCRIPTION NOTE |
|---|
| Source of description note |
Description based on print version record. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Record control number |
(DLC) 2014047836 |
